Overview of First Eagle Investment (Trades, Portfolio)'s Recent Trade
First Eagle Investment (Trades, Portfolio), a seasoned investment management firm, has recently adjusted its holdings in Universal Health Services Inc (UHS, Financial). On December 31, 2023, the firm reduced its stake in UHS by 11,836 shares, which resulted in a share change of -0.25%. The transaction was executed at a price of $152.44 per share. Following this trade, First Eagle Investment (Trades, Portfolio) holds a total of 4,630,429 shares in UHS, which represents 1.83% of their portfolio and 7.59% of the company's outstanding shares.
First Eagle Investment (Trades, Portfolio)'s Investment Philosophy
With roots dating back to 1864, First Eagle Investment (Trades, Portfolio) is an independent firm that prides itself on a value-oriented investment philosophy. The firm focuses on absolute long-term performance to preserve capital, employing rigorous bottom-up fundamental analysis to mitigate risk. First Eagle Investment (Trades, Portfolio)'s strategy includes on-site research and direct communication with company managers to thoroughly understand investment opportunities. The firm's portfolio is diverse, with top holdings in companies like Comcast Corp (CMCSA, Financial), Meta Platforms Inc (META, Financial), and Oracle Corp (ORCL, Financial), and a significant equity of $41.97 billion, primarily in the Technology and Basic Materials sectors.
Universal Health Services Inc at a Glance
Universal Health Services Inc, with the stock symbol UHS, is a prominent player in the Healthcare Providers & Services industry in the USA. Since its IPO on June 7, 1991, UHS has grown to own and operate a variety of healthcare facilities, including acute care hospitals and behavioral health centers. The company operates through segments such as Acute Care Hospital Services and Behavioral Health Services, among others.
Financial Snapshot of Universal Health Services Inc
Universal Health Services Inc boasts a market capitalization of $11.08 billion, with a current stock price of $162.38 and a PE ratio of 17.04. GuruFocus has assessed UHS as "Fairly Valued" with a GF Value of $173.95. The stock's price to GF Value ratio stands at 0.93, indicating that it is trading close to its intrinsic value. UHS has experienced a gain of 6.52% since the reported transaction and a year-to-date change of 3.82%. The stock has seen an impressive growth of 12,685.83% since its IPO.
First Eagle Investment (Trades, Portfolio)'s Position in UHS
After the recent transaction, First Eagle Investment (Trades, Portfolio)'s holdings in UHS account for a significant portion of their portfolio. Despite the reduction in shares, UHS remains a notable investment for the firm, reflecting their confidence in the stock's value and potential for long-term growth.
Universal Health Services Inc's Financial Health and Performance Rankings
UHS's financial health is solid, with a Financial Strength rank of 5/10 and a Profitability Rank of 9/10. The company's Growth Rank is at the top with a score of 10/10, and its GF Value Rank is 6/10. UHS also boasts a strong Momentum Rank of 10/10, indicating positive market sentiment.
Market Performance and Sentiment Indicators
UHS's stock momentum and RSI indicators suggest a strong performance, with RSI values of 67.41, 66.29, and 65.30 over 5, 9, and 14 days, respectively. The stock's momentum index rankings over the past month further reinforce its robust market presence.
Other Notable Investors in Universal Health Services Inc
First Eagle Investment (Trades, Portfolio) is not the only prominent investor in UHS. Other notable investors include Richard Pzena (Trades, Portfolio), HOTCHKIS & WILEY, and Joel Greenblatt (Trades, Portfolio), all of whom have recognized the potential in UHS's stock. First Eagle Investment (Trades, Portfolio) Management, LLC remains the largest guru shareholder, demonstrating the firm's significant influence and commitment to UHS.
Transaction Analysis
The recent reduction in First Eagle Investment (Trades, Portfolio)'s stake in UHS may reflect a strategic portfolio rebalancing rather than a loss of faith in the company's prospects. Given UHS's strong financial health, growth potential, and positive market indicators, the firm's remaining position in UHS still represents a vote of confidence in the company's future performance.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
